Table 2.
Hospitalization and hospital deaths
| Hospitalization and hospital deaths Exposed vs. unexposed (ref) | Pre-intervention | Intervention | Intervention add-on | ||||
|---|---|---|---|---|---|---|---|
| Exposed N = 652 |
Unexposed N = 17.248 |
Exposed N = 540 |
Unexposed N = 15.734 |
Exposed N = 326 |
Unexposed N = 9385 |
||
|
Hospitalized within the last 30 days OR (95% CI) |
n (%) | 412 (63%) | 10.712 (62%) | 350 (65%) | 9363 (60%) | 238 (73%) | 6001 (64%) |
| Crude | 1.06 (0.90–1.25) | 1.25 (1.05–1.50) | 1.53 (1.19–1.96) | ||||
| Adjusted*** | 1.20 (1.02–1.42) | 1.35 (1.12–1.62) | 1.62 (1.26–2.01) | ||||
|
Hospital admissions within the last 30 days RR (95% CI) |
Median (range) | 1 (0–4) | 1 (0–7) | 1 (0–3) | 1 (0–6) | 1 (0–4) | 1 (0–6) |
| Crude | 1.00 (0.92–1.09) | 1.08 (0.99–1.19) | 1.11 (0.99–1.24) | ||||
| Adjusted** | 1.06 (0.97–1.16) | 1.13 (1.03–1.24) | 1.13 (1.01–1.27) | ||||
| Length of stay estimate (95% CI) | Median (range) | 3 (0–30) | 3 (0–30) | 4.5 (0–30) | 3 (0–30) | 5 (0–30) | 3 (0–30) |
| Crude | 1.09 (0.96–1.24) | 1.26 (1.10–1.46) | 1.20 (1.01–1.42) | ||||
| Adjusted* | 1.16 (1.02–1.31) | 1.29 (1.12–1.49) | 1.21 (1.02–1.44) | ||||
|
Hospital deaths OR (95% CI) |
n (%) | 335 (51%) | 7923 (46%) | 288 (53%) | 6155 (39%) | 160 (49%) | 3140 (34%) |
| Crude | 1.24 (1.06–1.45) | 1.78 (1.50–2.11) | 1.91 (1.54–2.39) | ||||
| Adjusted*** | 1.43 (1.21–1.68) | 1.92 (1.60–2.29) | 1.94 (1.55–2.44) | ||||
Exposed: Patients exposed to PalMaGiC—palliative care case management intention for gastrointestinal cancer. Unexposed: Patients with gastrointestinal cancer are in standard care
*Crude and adjusted negative binomial regression analysis adjusted for age, gender, diagnosis, Charlson Comorbidity Index, education level, cohabitation status, and admission to specialized palliative care
**Crude and Adjusted Poisson regression analysis adjusted for age, gender, diagnoses, Charlson Comorbidity Index, education level, cohabitation status, and admission to specialized palliative care
***Crude and Adjusted logistic regression analysis adjusted for age, gender, diagnoses, Charlson Comorbidity Index, education level, cohabitation status, and admission to specialized palliative care